+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rx To OTC Switches"

The United States Market for Rx-to-OTC Switches, 8th Edition - Product Thumbnail Image

The United States Market for Rx-to-OTC Switches, 8th Edition

  • Report
  • May 2022
  • 195 Pages
  • United States
From
Consumer Health in Western Europe - Product Thumbnail Image

Consumer Health in Western Europe

  • Report
  • April 2024
  • 59 Pages
From
OTC Drug Regulations - Webinar (Recorded) - Product Thumbnail Image

OTC Drug Regulations - Webinar (Recorded)

  • Webinar
  • October 2019
  • 180 Minutes
  • Global
  • 3 Results (Page 1 of 1)
Loading Indicator

The Rx to OTC Switches market is a subset of the Over the Counter (OTC) Drugs market. It refers to the process of transitioning a prescription drug to an OTC drug, allowing consumers to purchase the drug without a prescription. This process is regulated by the FDA and requires the drug to meet certain safety and efficacy standards. The Rx to OTC Switches market is driven by the increasing demand for OTC drugs, as well as the need for cost-effective treatments. Additionally, the rise of e-commerce and digital health technologies has enabled more efficient and convenient access to OTC drugs. Some companies in the Rx to OTC Switches market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Bayer. Show Less Read more